# Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

> **NCT00001765** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 60 (—)

## Conditions studied

- Chronic Granulomatous Disease

## Interventions

- **DEVICE:** Nexell Isolex with T-cell Depletion
- **DEVICE:** Baxter isolex 300i

## Key facts

- **NCT ID:** NCT00001765
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 60 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001765, "Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00001765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*